Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Genetic Variation – The Need for Opioids During Surgery
This study has been completed.
Sponsored by: Rikshospitalet University Hospital
Information provided by: Rikshospitalet University Hospital
ClinicalTrials.gov Identifier: NCT00327938
  Purpose

The purpose of this study is to find out if the tetanic noxious stimuli and the measured skin conductance response can be used as a test in patients before surgery to have an indication about what amount of analgesics the patient will need during surgery.


Condition Intervention
Pain
Device: Measuring of skin conductance
Procedure: Tetanic stimuli

Drug Information available for: Remifentanil Remifentanil hydrochloride
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Double-Blind, Uncontrolled, Single Group Assignment, Safety Study
Official Title: Genetically Variation – May the Need of Opioids During Surgery be Known Beforehand by Giving Noxious Stimulation and Measure the Skin Conductance Response Before Surgery?

Further study details as provided by Rikshospitalet University Hospital:

Primary Outcome Measures:
  • skin conductance response

Estimated Enrollment: 50
Study Start Date: May 2006
Detailed Description:

Skin Conductance (SC) shows the emotional state as reflected in changes in the sympathetic nervous system. During sleep or other states of low basic sympathetic activity, activation of the sympathetic nervous system results in filling of the palmar and plantar sweat glands, and the SC increases transiently before the sweat is removed and the SC decreases again. When a short lasting outgoing sympathetic nervous burst occurs, fluctuations of SC will follow. An increase in the number of SC fluctuations (NSCF) can therefore be interpreted as increased activity in this part of the sympathetic nervous system. When remifentanil, an opioid analgetic is given, NSCF is reduced.

Genetic variation influences the pharmacokinetics and the pharmacodynamics of analgesics like morphine derivates and remifentanil. 50 female patients will therefore be blood tested to study if they are Val/Val or Met/Met for the COMT gene, or if they are homozygous or heterozygous for the 118G allele and the 118A allele.

This study will show if skin conductance can be used to measure noxious stimulation response before surgery (by giving a tetanic stimuli), and then predict what level of analgesic a patient will need during surgery.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Women in American Society of Anesthesiologists (ASA) group 1-2 and with body mass index between 20 and 30 and going through laparoscopic surgery at the Gynecological Department, Ullevål University Hospital.
  • Normal renal and hepar function (serum albumin and serum creatinine should be within the normal limit).

Exclusion Criteria:

  • Chronic pain in the last 6 months or recent use and abuse of analgesics.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00327938

Locations
Norway
Ulleval University Hospital
Oslo, Norway, 0407
Sponsors and Collaborators
Rikshospitalet University Hospital
Investigators
Study Director: Hanne Storm, PhD Rikshospitalet University Hospital
  More Information

Study ID Numbers: 2.2005.2354
Study First Received: May 18, 2006
Last Updated: April 19, 2007
ClinicalTrials.gov Identifier: NCT00327938  
Health Authority: Norway: The National Committees for Research Ethics in Norway

Keywords provided by Rikshospitalet University Hospital:
Remifentanil
Skin Conductance
Anesthesia
Analgesics, Opioid

Study placed in the following topic categories:
Remifentanil
Pain

ClinicalTrials.gov processed this record on January 14, 2009